Beneficial Effect of GFF MDI: A LAMA/LABA FDC Delivered by MDI Using Novel Cosuspension Technology on Inspiratory Capacity in Patients With COPD
نویسندگان
چکیده
منابع مشابه
Comparison of Bronchodilator Effect of Salbutamol Delivered via Mdi and Dpi in Copd Patients
Introduction : Chronic Obstructive Pulmonary Disease (COPD) is one of the leading problems affecting majority of population all over the world which diminishes the quality of life of the individual and create extra burden to the society as well as country. Inhaled bronchodilator therapy is the mainstay of treatment in the management of COPD. Various inhaled [e.g. metered dose inhaler (MDI) /dry...
متن کاملDose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD
BACKGROUND This study forms part of the first complete characterization of the dose-response curve for glycopyrrolate (GP) delivered using Co-Suspension™ Delivery Technology via a metered dose inhaler (MDI). We examined the lower GP MDI dose range to determine an optimal dose for patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). METHODS This randomized, double-bli...
متن کاملMdi
The story that we present tries to take readers on a journey of technological marvel, and attempts to show a little view of what the future can be like. After all, the sky's the ceiling, and we are far from our limits. Our story develops the action in the Earth and mention Kepler 4b and Kepler 7B planets to show that distances there are not a problem anymore and everybody can travel from one pl...
متن کامل24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD
BACKGROUND Symptoms of chronic obstructive pulmonary disease may vary throughout the day and it is important that therapeutic approaches provide 24-h symptom control. We report the results of two phase IIIb crossover studies, PT003011 and PT003012, investigating the 24-h lung function profile of GFF MDI (glycopyrrolate/formoterol fumarate 18/9.6 μg delivered using innovative co-suspension deliv...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2016
ISSN: 0012-3692
DOI: 10.1016/j.chest.2016.08.939